RxDoctor Payments Data

Suzanne Fenske

Obstetrics & Gynecology · New York, NYNPI 1881848794

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,935 of the $105,468 with a category attached, or 84.3%. AbbVie accounts for 73.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $65,622 and has fallen 99.4% since, to $379 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,468in general payments, 2019–2025

Across 191 payments — averaging $552.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$77K
  • Mayne Pharma Commercial LLC$27K
  • Astellas Pharma US Inc$257
  • Pfizer$227
  • Millicent US Inc$158
  • Evofem Biosciences, Inc.$145
  • plus $503 from 11 others

What the payments were for

  • Speaking & faculty fees$88,93584%
  • Travel & lodging$11,57511%
  • Food & beverage$4,8445%
  • Education$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$105,468 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Other obstetrics & gynecology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →